Relay Therapeutics, Inc. SEC filings RLAY
Relay Therapeutics, Inc. has 556 filings in SEC EDGAR's recent list, going back to May 22, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement
|
May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 11, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 6, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 11, 2025 | Jun 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 11, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Agreement ended
|
Jul 16, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2023 | May 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 18, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 15, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2022 | Sep 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 27, 2022 | May 27, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2021 | Dec 8, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 14, 2021 | Oct 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 8, 2021 | Oct 7, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
May 27, 2021 | May 26, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Apr 16, 2021 | Apr 15, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 14, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 27, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 21, 2020 | Jul 15, 2020 |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RLAY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1812364
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.